Welcome to our dedicated page for Fabrinet SEC filings (Ticker: FN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fabrinet (NYSE: FN) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of its regulatory record. As a Cayman Islands–incorporated issuer with operations in Thailand, the United States, the People’s Republic of China, and Israel, Fabrinet files detailed reports that explain its financial performance, governance practices, and executive compensation programs.
Through its annual reports on Form 10-K, Fabrinet presents audited financial statements, management’s discussion and analysis, and risk factor disclosures. These documents describe revenue trends across markets such as optical communications, automotive components, industrial lasers, medical devices, and sensors, as well as information on gross margins, operating margins, cash flows, and capital investments in manufacturing facilities and equipment.
Quarterly updates, often furnished via Form 8-K with attached earnings press releases, provide interim financial results and commentary from management. Fabrinet also uses Form 8-K to report material events such as leadership changes, board appointments and retirements, and the adoption of executive incentive plans and equity awards.
The company’s definitive proxy statement on Schedule 14A offers additional insight into corporate governance, including board structure, ESG practices and policies, director and executive compensation, and matters presented for shareholder vote at the Annual General Meeting. It details items such as the election of directors, ratification of the independent auditor, and advisory votes on named executive officer compensation.
On Stock Titan, Fabrinet’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain lengthy documents like the 10-K and proxy statement by highlighting key metrics, governance decisions, compensation structures, and risk discussions. Investors can also review Form 4 and other ownership-related filings to monitor insider transactions and equity awards, using the platform’s tools to quickly understand how these regulatory disclosures relate to Fabrinet’s broader financial and operational profile.
FN filed a Form 144 reporting a proposed sale of common stock through Morgan Stanley Smith Barney LLC as broker. The notice lists broker details and an intended transaction on 02/25/2026.
The filing also discloses that Thomas F. Kelly sold 2,200 common shares on 12/04/2025 for $1,021,111.30.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting 500 shares of common stock to be sold. The filing lists 500 shares associated with "Shares Purchased through Employee Stock Purchase Plan" and a transaction date of
Fabrinet reported strong growth for the quarter ended December 26, 2025. Revenues rose to
For the first six months of fiscal 2026, revenue reached
The company ended the quarter with cash and cash equivalents of
Fabrinet furnished a current report to share that it has released financial results for its fiscal quarter ended December 26, 2025. The company distributed these results in a press release dated February 2, 2026, which is included as Exhibit 99.1 to the report.
The report classifies this disclosure under results of operations and financial condition, and notes that the press release and related information are being furnished rather than filed under securities laws, which affects how they may be used in other regulatory filings.
T. Rowe Price Associates, Inc. reports beneficial ownership of 4,041,675 shares of Fabrinet common stock, representing 11.3% of the class as of 12/31/2025. The firm has sole voting power over 3,842,803 shares and sole dispositive power over 4,041,666 shares, with no shared voting or dispositive power.
The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Fabrinet, according to the certification. T. Rowe Price Associates also states that this filing should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.
Fabrinet director Frank H. Levinson reported an equity award in the company’s ordinary shares. On 12/11/2025, he received 417 restricted share units as part of his compensation for serving on the Board of Directors. Each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock at no purchase price.
The units will vest on January 1, 2027, provided he continues to serve on the board through that date. Following this grant, Levinson beneficially owns 7,021 ordinary shares on a direct basis. This is a routine Form 4 insider report documenting director equity compensation rather than an open-market share purchase.
Fabrinet director reports new restricted share unit grant
A Fabrinet director reported receiving 417 restricted share units on December 11, 2025 as part of compensation for serving on the company’s Board of Directors. Each unit represents a contingent right to receive one Fabrinet ordinary share at a price of $0 per share upon vesting. These units are scheduled to vest on January 1, 2027, as long as the director continues to serve through that date. After this award, the director beneficially owns 19,181 ordinary shares in total, held directly.
Fabrinet director receives restricted share units as board compensation
A Fabrinet director reported receiving 417 restricted share units of the company’s ordinary shares on December 11, 2025. These units were granted as partial compensation for service on the Board of Directors and carry a grant price of $0, reflecting that they are an incentive award rather than a market purchase.
Each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock. The units will vest on January 1, 2027, provided the director continues to serve on the board through that date. Following this grant, the director is reported to beneficially own 510 ordinary shares directly.
Fabrinet director reports equity compensation grant. A Form 4 filing discloses that a director of Fabrinet received 417 restricted share units of the company’s ordinary shares on 12/11/2025 at a stated price of $0, reflecting a compensation award rather than an open-market purchase.
After this grant, the director beneficially owns 18,733 ordinary shares. The filing notes that each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock, and the entire award is scheduled to vest on January 1, 2027, provided the director continues to serve on the board through that date.
Fabrinet director reports new equity award. A member of Fabrinet's Board of Directors reported receiving 417 restricted share units on December 11, 2025 as partial compensation for board service. Each unit represents a contingent right to receive one ordinary share of Fabrinet stock at a price of $0 per share.
The restricted share units will vest on January 1, 2027, as long as the director continues to serve on the board through that date. Following this grant, the director beneficially owns 1,773 ordinary shares directly, reflecting a modest increase in personal alignment with shareholder interests.